Significance of neutralizing antibodies to interferon beta during treatment of multiple sclerosis: expert opinions based on the proceedings of an International Consesus conference

H.P. Hartung; H. Schellekens; F. Munschauer

Significance of neutralizing antibodies to interferon beta during treatment of multiple sclerosis: expert opinions based on the proceedings of an International Consesus conference

H.P. Hartung, H. Schellekens, F. Munschauer

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	588-601
Number of pages	14
Journal	European Journal of Neurology
Volume	12
Publication status	Published - 2005

Cite this

@article{0ceae75e86c1477c9dd9b22bc92570cd,

title = "Significance of neutralizing antibodies to interferon beta during treatment of multiple sclerosis: expert opinions based on the proceedings of an International Consesus conference",

author = "H.P. Hartung and H. Schellekens and F. Munschauer",

year = "2005",

language = "Undefined/Unknown",

volume = "12",

pages = "588--601",

journal = "European Journal of Neurology",

issn = "1351-5101",

publisher = "Wiley-Blackwell",

}

Significance of neutralizing antibodies to interferon beta during treatment of multiple sclerosis: expert opinions based on the proceedings of an International Consesus conference. / Hartung, H.P.; Schellekens, H.; Munschauer, F.
In: European Journal of Neurology, Vol. 12, 2005, p. 588-601.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Significance of neutralizing antibodies to interferon beta during treatment of multiple sclerosis: expert opinions based on the proceedings of an International Consesus conference

AU - Hartung, H.P.

AU - Schellekens, H.

AU - Munschauer, F.

PY - 2005

Y1 - 2005

M3 - Article

SN - 1351-5101

VL - 12

SP - 588

EP - 601

JO - European Journal of Neurology

JF - European Journal of Neurology

ER -